Benzoate treatment beneficial in women with late stage dementia;JAMA

Medically Reviewed By : Dr. Kamal Kant Kohli

Published On 2021-04-26 00:18 GMT | Update On 2021-04-26 00:18 GMT

Benzoate treatment may improve cognitive function in women with later-phase dementia, suggests findings from a recently published study in JAMA .

"In the future, longer dose-finding trials are warranted to further clarify the efficacy of benzoate for later-phase dementia and investigate the role of sex hormones and other factors in the pathogenesis of dementia."the research team opined.

Female gender is a major risk factor for dementia; however, gender has not yet been adequately addressed by clinical trials. A recent study has demonstrated that sodium benzoate, a D-amino acid oxidase inhibitor, improved cognitive function in early-phase Alzheimer disease.

To gain deeper understanding on this, the team undertook the current study to examine the potential gender difference in the effects of benzoate treatment on the behavioral and psychological symptoms of dementia (BPSD).

This post hoc secondary analysis used data from a randomized, double-masked, placebo-controlled trial conducted in 3 major medical centers in Taiwan and enrolled 97 patients with BPSD. Data were analyzed between February 2014 and November 2017. Six weeks of treatment of 250 to 1500 mg/d of sodium benzoate or placebo. The primary outcome measures were Alzheimer disease assessment scale–cognitive subscale (ADAS-cog) and Behavioral Pathology in Alzheimer Disease Rating Scale (BEHAVE-AD) scores.

Data analysis revealed some interesting facts.

Among 97 total participants (62 [64%] women; mean [SD] age, 75.4 [7.7] years), 49 patients (30 women and 19 men) were randomized to sodium benzoate, and 48 (32 women and 16 men) were randomized to placebo.
Among 62 women, 6-week benzoate treatment significantly surpassed placebo in the effects on ADAS-cog performance (mean [SD] difference in score between baseline and end point, −3.1 [6.4] points vs 0 [4.5] points; Cohen d = 0.56; P = .04) but not BEHAVE-AD performance.
In contrast, among 35 men, the 2 treatment groups did not differ significantly in both ADAS-cog and BEHAVE-AD scores.
Compared with placebo, benzoate treatment also increased estradiol to follicle-stimulating hormone ratios among women (mean [SD] difference between baseline and end point, 0 [0.2] vs −0.1 [0.3]; P = .03).

"When considering the results of this post hoc secondary analysis of a randomized clinical trial on later-phase dementia with behavioral and psychological symptoms alongside our previous clinical trial on early-phase dementia, sodium benzoate, an indirect NMDAR agonist, can improve the cognitive function of all patients with early-phase dementia, but only benefit the cognitive function of female patients with later-phase dementia and behavioral and psychological symptoms. More studies are warranted to elucidate the underlying mechanisms." the team concluded.

Primary source: JAMA Network Open

For the full article follow the link: doi:10.1001/jamanetworkopen.2021.6156

Article Source : JAMA Network Open

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Dr Satabdi Saha

Dr Satabdi Saha (BDS, MDS) is a practicing pediatric dentist with a keen interest in new medical researches and updates. She has completed her BDS from North Bengal Dental College ,Darjeeling. Then she went on to secure an ALL INDIA NEET PG rank and completed her MDS from the first dental college in the country – Dr R. Ahmed Dental College and Hospital. She is currently attached to The Marwari Relief Society Hospital as a consultant along with private practice of 2 years. She has published scientific papers in national and international journals. Her strong passion of sharing knowledge with the medical fraternity has motivated her to be a part of Medical Dialogues.

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Benzoate treatment beneficial in women with late stage dementia;JAMA

Similar News

Severe Gum Disease Strongly Linked to Chronic Illnesses, Large U.S. Study Finds

Fetal Embolization Exhibits Early Success in High-Risk Vein of Galen Malformation: JAMA

Blood test may rule out future dementia risk: Study

New discovery reveals the role of spinal cord in bladder control

Does a diabetes drug help prevent dementia?

Poor Sleep Patterns Linked to 65 Percent Higher Risk of Abdominal Aortic Calcification in Adults: Study Finds

Pregnancy Complications Like Stillbirth and Preeclampsia May Predict Stroke Risk Before 50: Study Finds

FDA Approves Ajovy for Preventive Treatment of Episodic Migraine in Children Aged 6-17